IQVIA Holdings Reports Strong Q2 Results, Raises Full-Year Revenue Outlook
IQVIA Holdings (NYSE:IQV) rose sharply following its strong second-quarter performance and an upward revision of its full-year revenue outlook. The healthcare technology company reported a year-on-year revenue increase of 8.7% to $4.37 billion in Q2, driven by growth across all business segments. However, attributable net income declined slightly by 3.7% to $256 million during the same period. For FY26, IQVIA raised its projected revenues from $17.15–$17.35 billion to $17.275–$17.475 billion and expects adjusted EBITDA of $4–$4.05 billion compared to the previous forecast of $3.975–$4.025 billion. The company also increased its guidance for adjusted diluted earnings per share from $12.65–$12.95 to $12.8–$13. Institutional investor participation in IQVIA has weakened, with hedge fund holdings dropping by 53% in Q1 compared to the prior quarter. Despite this, the company announced a significant share repurchase program of up to $2.8 billion under its expanded buyback authorization.
Tickers: $IQV
Topics: FY26 outlook Q2 performance revenue growth